Filed: 11/14/2025ACC: 0001104659-25-112378
📋 What this filing means
ACUTA CAPITAL PARTNERS, LLC filed this quarterly 13F‑HR report disclosing 28 equity positions with a total reported market value of $96.77M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
28
Positions
$96.77M
Total AUM (reported)
8.24M
Total Shares
Allocation by class
COM$55.21M57.1%
COM NEW$22.27M23.0%
SPONSORED ADR$6.65M6.9%
COM PAR $.01$5.56M5.7%
SHS USD$3.31M3.4%
COM SHS$1.96M2.0%
ORDINARY SHARES$1.79M1.8%
Portfolio Concentration
Top 3$40.01M41.4%
4–10$33.51M34.6%
11–25$22.58M23.3%
Rest$672.7K0.7%
Top 3 weight
41.4%
Top 10 weight
76.0%
Voting Authority Distribution
Total shares with voting rights: 8.24M
Sole
Full voting authority
8.24M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole28
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings28
Rows:
OCULAR THERAPEUTIX INC
SOLEShares1.17M
TypeSH
Market value$13.62M
14.08%
Sole
1.17M
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares141.53K
TypeSH
Market value$13.55M
14.01%
Sole
141.53K
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares268.45K
TypeSH
Market value$12.84M
13.27%
Sole
268.45K
Shared
0.00
None
0.00
WHITEHAWK THERAPEUTICS INC
SOLEShares3.41M
TypeSH
Market value$6.48M
6.70%
Sole
3.41M
Shared
0.00
None
0.00
INSMED INC
SOLEShares38.59K
TypeSH
Market value$5.56M
5.74%
Sole
38.59K
Shared
0.00
None
0.00
BRIGHT MINDS BIOSCIENCES INC
SOLEShares84.88K
TypeSH
Market value$5.15M
5.32%
Sole
84.88K
Shared
0.00
None
0.00
ARGEN SE - ADR
SOLEShares6.38K
TypeSH
Market value$4.70M
4.86%
Sole
6.38K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares333.26K
TypeSH
Market value$4.53M
4.68%
Sole
333.26K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares502.80K
TypeSH
Market value$3.78M
3.90%
Sole
502.80K
Shared
0.00
None
0.00
JAZZ PHARMACEUTICALS PLC
SOLEShares25.11K
TypeSH
Market value$3.31M
3.42%
Sole
25.11K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares840.09K
TypeSH
Market value$2.94M
3.04%
Sole
840.09K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares49.75K
TypeSH
Market value$2.64M
2.72%
Sole
49.75K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares178.41K
TypeSH
Market value$2.30M
2.38%
Sole
178.41K
Shared
0.00
None
0.00
ASCENDIS PHA-ADR
SOLEShares9.79K
TypeSH
Market value$1.95M
2.01%
Sole
9.79K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares10.57K
TypeSH
Market value$1.87M
1.93%
Sole
10.57K
Shared
0.00
None
0.00
OCULIS HOLDING AG
SOLEShares101.78K
TypeSH
Market value$1.79M
1.85%
Sole
101.78K
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares454.83K
TypeSH
Market value$1.49M
1.54%
Sole
454.83K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares102.91K
TypeSH
Market value$1.48M
1.53%
Sole
102.91K
Shared
0.00
None
0.00
ZYMEWORKS INC
SOLEShares80.14K
TypeSH
Market value$1.37M
1.41%
Sole
80.14K
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares143.45K
TypeSH
Market value$1.27M
1.31%
Sole
143.45K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares25K
TypeSH
Market value$983.8K
1.02%
Sole
25K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP
SOLEShares2.30K
TypeSH
Market value$962.5K
0.99%
Sole
2.30K
Shared
0.00
None
0.00
INHIBRX BIOSCIENCES INC
SOLEShares16.38K
TypeSH
Market value$551.6K
0.57%
Sole
16.38K
Shared
0.00
None
0.00
FULCRUM THERAPEUTICS INC
SOLEShares57.14K
TypeSH
Market value$525.7K
0.54%
Sole
57.14K
Shared
0.00
None
0.00
LB PHARMACEUTICALS INC
SOLEShares30K
TypeSH
Market value$473.7K
0.49%
Sole
30K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
OCULAR THERAPEUTIX INCSOLE | COM | 1.17M | SH | $13.62M 14.08% | 1.17M | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | COM NEW | 141.53K | SH | $13.55M 14.01% | 141.53K | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | COM | 268.45K | SH | $12.84M 13.27% | 268.45K | 0.00 | 0.00 |
WHITEHAWK THERAPEUTICS INCSOLE | COM | 3.41M | SH | $6.48M 6.70% | 3.41M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 38.59K | SH | $5.56M 5.74% | 38.59K | 0.00 | 0.00 |
BRIGHT MINDS BIOSCIENCES INCSOLE | COM NEW | 84.88K | SH | $5.15M 5.32% | 84.88K | 0.00 | 0.00 |
ARGEN SE - ADRSOLE | SPONSORED ADR | 6.38K | SH | $4.70M 4.86% | 6.38K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 333.26K | SH | $4.53M 4.68% | 333.26K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 502.80K | SH | $3.78M 3.90% | 502.80K | 0.00 | 0.00 |
JAZZ PHARMACEUTICALS PLCSOLE | SHS USD | 25.11K | SH | $3.31M 3.42% | 25.11K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 840.09K | SH | $2.94M 3.04% | 840.09K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM | 49.75K | SH | $2.64M 2.72% | 49.75K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM NEW | 178.41K | SH | $2.30M 2.38% | 178.41K | 0.00 | 0.00 |
ASCENDIS PHA-ADRSOLE | SPONSORED ADR | 9.79K | SH | $1.95M 2.01% | 9.79K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 10.57K | SH | $1.87M 1.93% | 10.57K | 0.00 | 0.00 |
OCULIS HOLDING AGSOLE | ORDINARY SHARES | 101.78K | SH | $1.79M 1.85% | 101.78K | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 454.83K | SH | $1.49M 1.54% | 454.83K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 102.91K | SH | $1.48M 1.53% | 102.91K | 0.00 | 0.00 |
ZYMEWORKS INCSOLE | COM | 80.14K | SH | $1.37M 1.41% | 80.14K | 0.00 | 0.00 |
VERASTEM INCSOLE | COM NEW | 143.45K | SH | $1.27M 1.31% | 143.45K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 25K | SH | $983.8K 1.02% | 25K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORPSOLE | COM | 2.30K | SH | $962.5K 0.99% | 2.30K | 0.00 | 0.00 |
INHIBRX BIOSCIENCES INCSOLE | COM | 16.38K | SH | $551.6K 0.57% | 16.38K | 0.00 | 0.00 |
FULCRUM THERAPEUTICS INCSOLE | COM | 57.14K | SH | $525.7K 0.54% | 57.14K | 0.00 | 0.00 |
LB PHARMACEUTICALS INCSOLE | COM SHS | 30K | SH | $473.7K 0.49% | 30K | 0.00 | 0.00 |
Page 1 of 2